TNGX
Tango Therapeutics Inc

654
Mkt Cap
$1.23B
Volume
1.71M
52W High
$11.20
52W Low
$1.03
PE Ratio
-9.93
TNGX Fundamentals
Price
$9.10
Prev Close
$9.17
Open
$9.17
50D MA
$8.59
Beta
1.26
Avg. Volume
3.19M
EPS (Annual)
-$1.19
P/B
6.34
Rev/Employee
$271,412.90
Loading...
Loading...
News
all
press releases
Stempoint Capital LP Acquires Shares of 208,800 Tango Therapeutics, Inc. $TNGX
Stempoint Capital LP acquired a new position in shares of Tango Therapeutics, Inc. (NASDAQ:TNGX - Free Report) in the second quarter, according to the company in its most recent 13F filing with the...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Tango Therapeutics (NASDAQ:TNGX) Stock Price Down 4.6% - Should You Sell?
Tango Therapeutics (NASDAQ:TNGX) Trading Down 4.6% - Here's Why...
MarketBeat·2d ago
News Placeholder
Vivo Capital LLC Purchases Shares of 600,000 Tango Therapeutics, Inc. $TNGX
Vivo Capital LLC purchased a new position in shares of Tango Therapeutics, Inc. (NASDAQ:TNGX - Free Report) in the second quarter, according to the company in its most recent filing with the...
MarketBeat·3d ago
News Placeholder
Can Tango Therapeutics (TNGX) Climb 37.28% to Reach the Level Wall Street Analysts Expect?
The mean of analysts' price targets for Tango Therapeutics (TNGX) points to a 37.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks·4d ago
News Placeholder
Geode Capital Management LLC Grows Position in Tango Therapeutics, Inc. $TNGX
Geode Capital Management LLC raised its position in Tango Therapeutics, Inc. (NASDAQ:TNGX - Free Report) by 27.9% in the second quarter, according to the company in its most recent Form 13F filing...
MarketBeat·7d ago
News Placeholder
Tango Therapeutics (NASDAQ:TNGX) Shares Gap Down - Here's Why
Tango Therapeutics (NASDAQ:TNGX) Shares Gap Down - What's Next...
MarketBeat·15d ago
News Placeholder
Tango Therapeutics (NASDAQ:TNGX) Sees Unusually-High Trading Volume - Should You Buy?
Tango Therapeutics (NASDAQ:TNGX) Sees Strong Trading Volume - What's Next...
MarketBeat·16d ago
News Placeholder
Tango Therapeutics (NASDAQ:TNGX) Hits New 52-Week High - Time to Buy?
Tango Therapeutics (NASDAQ:TNGX) Sets New 12-Month High - Here's Why...
MarketBeat·19d ago
News Placeholder
Tango Therapeutics (NASDAQ:TNGX) Trading 7.4% Higher - Here's What Happened
Tango Therapeutics (NASDAQ:TNGX) Trading 7.4% Higher - Here's Why...
MarketBeat·20d ago
News Placeholder
Wall Street Analysts See a 46.07% Upside in Tango Therapeutics (TNGX): Can the Stock Really Move This High?
The mean of analysts' price targets for Tango Therapeutics (TNGX) points to a 46.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks·21d ago

Latest TNGX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.